SCHEMBL12756722

SCHEMBL12756722

O=C(CCc1ccco1)Nc1csc(-c2ccc(Cl)cc2)c1C(=O)O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NTRK1 P04629 1/20 0.49
▸ HDAC1 Q13547 1/20 0.41
▸ HDAC6 Q9UBN7 1/20 0.41
▸ KDM4E B2RXH2 4/20 0.41
▸ NPSR1 Q6W5P4 2/20 0.41
▸ ALDH1A1 P00352 4/20 0.40
▸ MAPK1 P28482 3/20 0.40
▸ MAPT P10636 2/20 0.40
▸ POLB P06746 2/20 0.40
▸ HSD17B10 Q99714 1/20 0.40
▸ KMT2A Q03164 3/20 0.40
▸ MEN1 O00255 2/20 0.40
▸ TNKS2 Q9H2K2 1/20 0.39
▸ LMNA P02545 2/20 0.39
▸ TP53 P04637 2/20 0.39
▸ NPC1 O15118 1/20 0.39
▸ RAB9A P51151 1/20 0.39
▸ RECQL P46063 1/20 0.38
▸ CASP1 P29466 1/20 0.37
▸ SMN1; SMN2 Q16637 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12756721 0.90 NTRK1 (0.49) NTRK1HDAC1HDAC6KDM4ENPSR1
SCHEMBL12756646 0.84 ANO1 (0.45) ALDH1A1MAPK1MAPTKMT2AMEN1
SCHEMBL1490241 0.84 ALOX15 (0.53) MAPK1MAPTKMT2AMEN1LMNA
SCHEMBL1490370 0.83 HCAR2 (0.47) HDAC1HDAC6MAPK1KMT2AMEN1
SCHEMBL12756718 0.83 MEN1 (0.44) HDAC1HDAC6KDM4ENPSR1ALDH1A1
SCHEMBL12756649 0.82 HCAR2 (0.43) MAPK1KMT2AMEN1TNKS2NPC1
SCHEMBL1952182 0.81 KDM4E (0.57) NTRK1KDM4ENPSR1ALDH1A1MAPT
SCHEMBL1490454 0.80 HCAR2 (0.50) ALDH1A1MAPK1KMT2AMEN1RAB9A
SCHEMBL12756667 0.80 POLB (0.40) HDAC1HDAC6ALDH1A1MAPK1MAPT
SCHEMBL12756631 0.80 NPY5R (0.51) HDAC1HDAC6ALDH1A1MAPK1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140051711-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA INC. (US) 2014-02-20 — — US disclosed
US-20140051711-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA INC. (US) 2014-02-20 — — US disclosed
WO-2011034962-A2 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA INC. (US) 2011-03-24 — — WO disclosed
US-20110065724-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA, INC. (US) 2011-03-17 — — US disclosed
US-20110065724-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA, INC. (US) 2011-03-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140051711-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM ORAI1, SARAF, RYR2 NTRK1 4722/4885HDAC1 2696/4885HDAC6 1662/4885
US-20110065724-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM ORAI1, SARAF, RYR2 NTRK1 4722/4885HDAC1 2696/4885HDAC6 1662/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback